GF Fund Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
Other funds holding NTLA
GF Fund Management's NTLA Position: Q3 2026 in Review
GF Fund Management increased its Intellia Therapeutics (NTLA) stake by 76% in Q3 2026, buying an estimated $23.9K and bringing the position to 4,413 shares worth $53.2K. The position accounts for ﹤0.01% of the portfolio, ranked #385.
GF Fund Management first reported a position in NTLA in Q4 2024 and has held it in 8 quarters since. 312 funds tracked by Wall St. Rank hold NTLA as of Q3 2026.
- GF Fund Management held 4,413 shares of Intellia Therapeutics worth $53.2K as of Q3 2026.
- GF Fund Management bought 1,911 Intellia Therapeutics shares in Q3 2026, an estimated $23.9K.
- Intellia Therapeutics made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #385 holding.
- GF Fund Management first reported a position in Intellia Therapeutics in Q4 2024 and has held it in 8 quarters since.
- 312 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2026.
Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.